X

Biotechnology

Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better…

Ocean Biomedical presents novel malaria therapeutic discoveries at NIH Laboratory of Malaria Vaccinology and Immunology

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Fundamental Research Corp. initiates coverage of Ocean Biomedical (OCEA) with “Buy” recommendation

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday said that Fundamental Research Corp. initiated equity analyst coverage of its stock with…

Ocean Biomedical provides positive research data on anti-tumor pathway; stock climbs

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) released details of discoveries that have potential applications for tumor suppression across multiple…

Novavax Inc (NVAX) Q4 2022 Earnings Call Transcript

Novavax Inc (NASDAQ:NVAX) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Erika Schultz -- Senior Director of Investor Relations John…

Ocean Biomedical co-founder Jake Kurtis gets new patent for novel malaria vaccine target

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jonathan Kurtis received a new patent for his…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the…

Moderna (MRNA) Earnings: 4Q22 Key Numbers

Moderna Inc. (NASDAQ: MRNA) reported total revenue of $5.1 billion for the fourth quarter of 2022, down 29% year-over-year due…

Key highlights from Biogen’s (BIIB) Q4 2022 earnings results

Biogen Inc. (NASDAQ: BIIB) reported fourth quarter 2022 earnings results today. Total revenue fell 7% year-over-year to $2.54 billion. Net…

AbbVie sees near-term slowdown; looks prepared to tackle patent expiration

AbbVie, Inc. (NYSE: ABBV) has delivered yet another quarter of strong top-line and earnings performance but issued cautious guidance for…

Veru Inc (VERU) Q1 2023 Earnings Call Transcript

Veru Inc (NASDAQ: VERU) Q1 2023 earnings call dated Feb. 09, 2023 Corporate Participants: Sam Fisch -- Executive Director, Investor Relations, and Corporate…

AbbVie (ABBV) Q4 2022 Earnings: Key financials and quarterly highlights

AbbVie (NYSE: ABBV) reported fourth quarter 2022 earnings results today. Worldwide net revenues increased 1.6% year-over-year to $15.1 billion. Net…

CVS Earnings: CVS Health Q4 2022 profit, revenue increase

CVS Health Corporation (NYSE: CVS) on Wednesday announced financial results for the fourth quarter of 2022, reporting a modest increase…

Illumina Inc (ILMN) Q4 2022 Earnings Call Transcript

Illumina Inc (NASDAQ:ILMN) Q4 2022 Earnings Call dated Feb. 07, 2023. Corporate Participants: Salli Schwartz -- Vice-President of Investor Relations Francis deSouza -- President…

Vertex Pharmaceuticals Incorporated (VRTX) Q4 2022 Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q4 2022 earnings call dated Feb. 07, 2023 Corporate Participants: Susie Lisa -- Senior Vice President, Investor…

Earnings: Regeneron Pharmaceuticals (REGN) Q4 profit falls as revenues drop 31%

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Friday reported a sharp fall in fourth-quarter revenues and adjusted earnings. Total revenues plunged…

Merck (MRK) Earnings: 4Q22 Key Numbers

Merck (NYSE: MRK) reported fourth quarter 2022 earnings results today. Sales increased 2% year-over-year to $13.8 billion. GAAP net income…

BMY Earnings: Everything you need to know about Bristol Myers’ Q4 results

Bristol Myers Squibb (NYSE: BMY) on Thursday announced results for the fourth quarter of 2022, reporting lower earnings and revenues.…

AMGN Infographic: Amgen’s Q4 2022 profit drops on flat revenues

Amgen Inc. (NASDAQ: AMGN) said its revenues remained unchanged in the fourth quarter of 2022 when the biotechnology firm's earnings…

Infographic: How Abbott Laboratories (ABT) performed in Q4 2022 financial results

Abbott Laboratories (NYSE: ABT) reported fourth quarter 2022 earnings results today. Net sales declined 12% year-over-year to $10.1 billion. Net…

Cadrenal Therapeutics downsizes IPO, looks to raise $7 million

There has been an increase in the number of pharma companies taking the IPO route to enhance their research and…